| 000 | 01560nam a2200385 i 4500 | ||
|---|---|---|---|
| 999 |
_c260862 _d260862 |
||
| 001 | ocn991868224 | ||
| 003 | BD | ||
| 005 | 20171229153916.0 | ||
| 006 | m o d f | ||
| 007 | cr bn||||m|||| | ||
| 008 | 170627m20179999dcu o f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _epn _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 049 | _aBDDF | ||
| 050 | 1 | 4 |
_aKF32 _b.E55 2017 |
| 074 | _a1008-D (MF) | ||
| 086 | 0 | _aY 1.1/8:115-192/ | |
| 099 | _aY 1.1/8:115-192/ | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce, _eauthor. |
|
| 245 | 1 | 0 |
_aMedical Controlled Substances Transportation Act of 2017 : _breport (to accompany H.R. 1492). |
| 264 | 1 |
_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c[2017]- |
|
| 336 |
_amicroform _bh |
||
| 337 |
_amicrofiche _bhe |
||
| 338 | _2rdacarrier | ||
| 490 | 1 |
_aRept. / 115th Congress, 1st session, House of Representatives ; _v115-192 |
|
| 500 | _a"June 23, 2017"--Pt. 1. | ||
| 500 | _aCRDP Program record. | ||
| 588 | _aDescription based on online resource, PDF version; title from pt. 1 caption (FDsys web site, viewed on June 27, 2017). | ||
| 650 | 0 |
_aDrugs _xAdministration _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aInterstate commerce _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aMedical laws and legislation _zUnited States. |
|
| 655 | 7 |
_aLegislative materials. _2lcgft |
|
| 810 | 1 |
_aUnited States. _bCongress. _bHouse. _tReport ; _v115-192. |
|
| 856 | 4 | 0 | _uhttp://purl.fdlp.gov/GPO/gpo82113 |
| 942 |
_2sudocs _c12 |
||